MedTrace Logo

Tramadol Simultaneously With Sciatic Nerve Block for Calcaneus Fracture Osteosynthesis

NCT03477851 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-10-28

No results posted yet for this study

Summary

Comparison of duration of efficient analgesia after painful surgical repair od foot fractures between groups treated with sciatic nerve block alone and sciatic nerve block simultaneously with i.m. tramadol

Conditions

  • Foot Fracture
  • Pain, Acute

Interventions

DRUG

Tramadol Hydrochloride

Tramadol i.m. simultaneous with sciatic nerve block

DRUG

Placebo

0,9%NaCl i.m. simultaneous with sciatic nerve block

Sponsors & Collaborators

  • Medical University of Warsaw

    lead OTHER

Principal Investigators

  • Janusz Trzebicki, Dr hab. · Medical University of Warsaw

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-06-15
Primary Completion
2020-06-30
Completion
2020-12-30

Countries

  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03477851 on ClinicalTrials.gov